The World Health Organization is hoping to drive down the cost of insulin by encouraging more generic drug makers to enter the market. The organization hopes that by increasing competition for insulin, drug manufacturers will be forced to lower their prices. Currently, only three companies dominate the world insulin market, Eli Lilly, Novo Nordisk and […]